Signal from the log
Arctic Therapeutics
21,5 M$ · Islande · Biotech
Arctic Therapeutics, issue en 2015 d'un centre de génomique de l'hôpital pour enfants de Philadelphie, part de la génétique humaine pour trouver ses cibles. Son produit le plus avancé, AT-001, est un traitement oral contre une forme héréditaire rare de démence, testé aussi au début de la maladie d'Alzheimer.
Verified
Announced on , logged by the watch of 21 October 2026.
- Operation
- Funding round
- Announced amount
- 21,5 M$
- Country
- Islande
- Sector
- Biotech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Pekron , Sanos Group , Kaldbakur , Landvættir
Provenance
Source prnewswire,sifted
Logged on 21 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.